Bayer is set to cut cost of anthrax drug
The German based maker of the anthrax treatment Cipro has reached a tentative agreement with the U.S. government to significantly lower the drug's price.
The German based maker of the anthrax treatment Cipro has reached a tentative agreement with the U.S. government to significantly lower the drug's price.